The filing excerpts provided do not contain sufficient substantive business information about Innoviva Inc (INVA) to produce a SEC-grounded company description. The excerpts consist only of boilerplate SEC cover page language and do not disclose the company's business activities, revenue model, products, customers, geographic footprint, competitors, or financial results. No factual claims about Innoviva can be supported by the provided source material.

Source: SEC 10-K, filed 2026-02-25

Industry: Pharmaceutical Preparations Peers: Aclaris Therapeutics Inc AERIE PHARMACEUTICALS INC Amneal Pharmaceuticals Inc Belite Bio Inc Relmada Therapeutics Inc DICE Therapeutics, Inc. Johnson & Johnson REATA PHARMACEUTICALS INC SIGA Technologies Inc